Latest news with #PercutaneousCoronaryIntervention
Daily Express
4 days ago
- Health
- Daily Express
60-70pc patients require stenting
Published on: Sunday, June 01, 2025 Published on: Sun, Jun 01, 2025 By: Sherell Jeffrey Text Size: Dr Rowland simplifies the procedure by comparing stenting to plumbing. STENTING, which involves inserting a small tube into a blocked or narrowed vessel and open it to facilitate blood flow has become increasingly popular as an intervention procedure. Dr Rowland said roughly 60 to 70 per cent of patients with coronary artery disease require stenting, also known as Percutaneous Coronary Intervention (PCI). 'Patients typically present with unstable conditions where chest pain becomes frequent and severe, often accompanied by symptoms like difficulty breathing. We call this acute coronary syndrome or heart attack,' he said. As a Consultant Cardiologist, he has performed over 8,000 stenting procedures and in the process introduced several advanced techniques in East Malaysia, including intravascular ultrasound imaging, rotablation and shockwave lithotripsy for hardened blood vessels. With such technology available locally, Sabahans no longer need to fly to Kuala Lumpur or Singapore for the life-saving procedure. 'These advanced technologies have revolutionised how we treat coronary artery disease,' Dr Rowland told Daily Express. 'With rotablation, we can drill through severely calcified blockages that were previously impossible to treat. 'Shockwave lithotripsy allows us to break up hardened calcium deposits, while intravascular ultrasound gives us a cross-sectional view inside blood vessels to optimise stent placement.' The importance of this technology cannot be overstated as heart disease cases continue to rise in Sabah. 'Many patients present late, especially those from the interior where screening is not easily accessible. By the time they come to us, the only option is stenting because they have gone beyond the stage where medical therapy alone would help,' he said. Dr Rowland simplifies the procedure by comparing stenting to plumbing. 'Our heart has pipes (blood vessels) that can clog up. As interventional cardiologists, we are like professional plumbers. We try to open up narrowed vessels using micro balloons and then we put in a stent to support the structure,' he said. He said stenting is minimally invasive unlike bypass which requires open-heart surgery. 'We access the heart through blood vessels in the wrist or groin area by inserting a small catheter, connect it to the heart vessel and inject dye to see where the blockage is. A stent is then placed to open up the blockage. The injection of dye is called an angiogram, which provides an X-ray image of the heart vessels, while Angioplasty refers to the actual procedure of inserting a balloon or stent.
Yahoo
27-03-2025
- Health
- Yahoo
Lupin Digital Health Introduces Comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology
An initiative aimed at improving patient recovery and well-being following cardiac procedures Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: (BLOOMBERG: LPCIN) MUMBAI, India, March 27, 2025 /PRNewswire/ -- Lupin Digital Health (LDH), India's leading evidence-based Digital Therapeutics (DTx) platform, today announced the launch of its comprehensive Post-Procedure Home-Based Care Guide at India Live, an annual confluence of leading interventional cardiologists from the Asia Pacific Region, held at Jio World Convention Centre in Mumbai. This guide is based on the American College of Cardiology (ACC)'s 'Home-Based Care Workbook' and has been developed by LDH along with the workgroup constituted by the ACC. Co-authored by eminent cardiologists Dr. JPS Sawhney, Dr. Prafulla Kerkar, Dr. Harikrishnan and Dr. Aditya Kapoor along with Dr. Chetan Gharat, these user-friendly guides provide patients and caregivers with essential information and practical advice to manage post-procedure recovery at home. Covering conditions such as Heart Failure (HF), Arrhythmia, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Grafting (CABG), the guides help patients understand their recovery process, recognize potential complications, manage medications, make necessary lifestyle adjustments, and access cardiac rehabilitation resources. Mr. Rajeev Sibal, President – India Region Formulations, Lupin, emphasised the importance of patient-centric care, stating, "At Lupin, we believe empowering patients with the right knowledge is crucial for better health outcomes. This initiative by Lupin Digital Health, in partnership with the American College of Cardiology, provides structured guidance that simplifies recovery and enhances post-procedure care at home." Sidharth Srinivasan, CEO, Lupin Digital Health, added, "With the rising burden of cardiovascular diseases, improving home-based care is no longer optional—it is essential. These guides, developed in collaboration with leading cardiologists, offer patients the support they need to navigate recovery with confidence, reducing hospital readmissions and ensuring a smoother transition from hospital to home." Dr. Prafulla Kerkar, Senior Interventional Cardiologist, Asian Heart Institute, Mumbai, and Former HOD Cardiology, KEM Hospital Mumbai, stressed the importance of structured recovery, noting, "The transition from hospital to home can be a vulnerable period for cardiac patients. By equipping them with clear, actionable guidance, we can significantly improve their overall quality of life and reduce complications." Dr. Harikrishnan, HOD Cardiology, Sri Chitra Tirunal Institute, Trivandrum, highlighted the growing need for digital solutions, stating, "With heart failure rates rising at an alarming pace in India, leveraging digital infrastructure for specialized care is an urgent necessity. This collaboration enables early symptom detection, optimized medication management, and improved patient outcomes." This initiative underscores Lupin Digital Health's commitment to delivering evidence-based, high-quality educational resources that enhance patient recovery and long-term well-being. About the American College of Cardiology The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at or follow @ACCinTouch. About Lupin Digital Health Lupin Digital Health (LDH) is India's leader in chronic disease management, specializing in cardiovascular and metabolic conditions. Through a blend of AI-driven insights and expert-led care, LDH empowers patients and policyholders to achieve better health outcomes. Its flagship program, LYFE, provides remote cardiac rehabilitation and chronic disease management, helping reduce hospital readmissions, improve adherence, and enhance recovery. By seamlessly integrating into hospitals, insurers, and corporate wellness programs, LDH bridges gaps in long-term care, ensuring patients stay connected to their care teams beyond hospital discharge. With a commitment to accessible, scalable, and high-quality healthcare, LDH is redefining chronic disease management in India. For more information, visit or follow Lupin Digital Health on LinkedIn. About Lupin Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions. To know more, visit or follow us on LinkedIn Logo: View original content: Sign in to access your portfolio
Zawya
21-02-2025
- Health
- Zawya
Cleveland Clinic Abu Dhabi receives American College of Cardiology accreditation for excellence in Cardiac Catheterization and Percutaneous Coronary Intervention
Hospitals receiving Cardiac Cath Lab Accreditation with PCI from the ACC must undergo a comprehensive clinical process, including gap analysis, care variance review, action plan development, onsite evaluation, and ongoing monitoring Cleveland Clinic Abu Dhabi's Heart, Vascular & Thoracic Institute (HVTI) continues to set new benchmarks in advanced cardiac care in the region. In 2024, HVTI performed 839 procedures, including 574 cardiac surgeries and 265 structural heart interventions. Abu Dhabi, United Arab Emirates.: Cleveland Clinic Abu Dhabi, part of the M42 group, has earned the prestigious recognition from the American College of Cardiology (ACC) for its excellence in treating patients requiring cardiac catheterization procedures. Cleveland Clinic Abu Dhabi was awarded Cardiac Cath Lab Accreditation with Percutaneous Coronary Intervention (PCI) following a rigorous onsite evaluation of the staff's ability to evaluate, diagnose and treat patients in its state-of-the-art cardiac catheterization laboratory. Percutaneous coronary intervention, commonly known as coronary angioplasty, is a non-surgical procedure that opens narrowed or blocked coronary arteries with a balloon to relieve symptoms of heart disease or reduce heart damage during or after a heart attack. The hospital has also been recognized by the ACC as an International Center of Excellence for its commitment to comprehensive, high-quality culture and cardiovascular care. This designation is awarded to international hospitals that consistently demonstrate excellence through comprehensive process improvement, disease and procedure-specific accreditation, professional excellence, and community engagement. Cleveland Clinic Abu Dhabi is the Center of Excellence for adult cardiac surgery as accredited by the Department of Health- Abu Dhabi. Cleveland Clinic Abu Dhabi's Heart, Vascular & Thoracic Institute (HVTI) continues to set new benchmarks in advanced cardiac care in the region. In 2024, HVTI performed 839 procedures, including 574 cardiac surgeries and 265 structural heart interventions, showcasing its expertise in treating complex heart conditions. Since 2015, the institute has successfully completed 500 TAVI procedures, reflecting its leadership in minimally invasive heart treatments. The institute's Coronary Artery Disease Program further unites multidisciplinary experts including cardiologists, interventional cardiologists, and cardiac surgeons to provide comprehensive, individualized care for patients. Renowned for its leadership in robotically assisted and hybrid surgeries, HVTI is recognized as one of the world's leading centers and leads Cleveland Clinic's facilities in the United States for robotically assisted heart surgery. Dr. Georges-Pascal Haber, CEO at Cleveland Clinic Abu Dhabi said: 'This accreditation is a powerful testament to Cleveland Clinic Abu Dhabi's dedication to advancing healthcare excellence. It reflects our relentless drive to combine cutting-edge innovation, world-class expertise, and a patient-first philosophy to redefine the standards of care in the region. This milestone not only highlights the exceptional work of our Heart, Vascular & Thoracic Institute but also reinforces our commitment to leading the way in transforming cardiovascular care for patients in the UAE and beyond. As we continue to push the boundaries of what's possible in medicine, we remain steadfast in our mission to improve lives and deliver unparalleled care." Deepak L. Bhatt, MD, MPH, FACC, chair of the ACC Accreditation Management Board said: 'Cleveland Clinic Abu Dhabi has demonstrated its commitment to providing patients in UAE and from across the world with excellent heart care. The hospital has proven to be a forward-thinking institution with goals to advance the cause of sustainable quality improvement. ACC Accreditation Services is proud to award Cleveland Clinic Abu Dhabi with Cardiac Cath Lab Accreditation with PCI.' Hospitals receiving Cardiac Cath Lab Accreditation with PCI from the ACC must take part in a multi-faceted clinical process that involves completing a gap analysis, examining variances of care, developing an action plan, a rigorous onsite review, and monitoring for sustained success. Improved methods and strategies of caring for patients include streamlining processes, implementing guidelines and standards, and adopting best practices in the care of cath lab patients. Facilities that achieve accreditation meet or exceed an array of stringent criteria and have organized a team of doctors, nurses, clinicians, and other administrative staff that earnestly support the efforts leading to improved patient outcomes. Dr. Ronney Shantouf, Director of the Cardiac Catheterization Lab, co-Director of the Complex Coronary Program, and co-Director of the Invasive Coronary Spasm and Microvascular Dysfunction Program at Cleveland Clinic Abu Dhabi said: 'This accreditation is a proud moment for Cleveland Clinic Abu Dhabi and reflects our dedication to providing the highest standards of cardiac care. Advances in cardiac catheterization procedures, such as percutaneous coronary intervention, have transformed the way we treat complex heart conditions, offering patients safer and less invasive options with faster recovery times. At Cleveland Clinic Abu Dhabi, we combine state-of-the-art technology with a highly skilled team to ensure each patient receives tailored, life-saving care. This recognition is a testament to our ongoing commitment to improving outcomes and enhancing the quality of life for our patients." Hospitals that have proven exceptional competency in cardiac catheterization follow strict processes to ensure quality and patient safety. During the procedure, they careful manage steps like sedation, infection control, radiation safety, and time out procedures to ensure everything is fully coordinated. They also need to master the appropriate transfer to a cath recovery unit to better monitor and track complications, enhance physician-to-patient communication, patient family communication, discharge instructions and follow-up information. About Cleveland Clinic Abu Dhabi Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital located on Al Maryah Island in Abu Dhabi, UAE. As an extension of Cleveland Clinic in the U.S., it is uniquely designed to address the complex and critical care needs of the UAE and the broader region. The hospital is organized into specialized Institutes, including Heart, Vascular & Thoracic; Neurological; Cancer; Digestive Disease; Medical Subspecialties; Integrated Surgical Subspecialties; Integrated Hospital Care; and Diagnostic. Celebrating its 10th anniversary in 2025, Cleveland Clinic Abu Dhabi is a 405-bed hospital, including 321 acute care beds, 84 critical care beds, four royal suites, and 26 operating rooms. Its state-of-the-art facilities provide patients in the region with direct access to world-class healthcare providers and Cleveland Clinic's renowned model of care. The hospital is also home to the Fatima bint Mubarak Center, a dedicated cancer center offering comprehensive diagnostics and advanced treatment across 24 clinical departments, covering a range of cancer subspecialties and programs. Committed to medical innovation, Cleveland Clinic Abu Dhabi integrates robotics across specialties, pioneers endovascular therapy and hybrid procedures, and offers comprehensive programs in heart failure, heart transplantation, and limb salvage. Licensed by the Department of Health – Abu Dhabi as a designated research and teaching facility, Cleveland Clinic Abu Dhabi drives medical innovation through clinical trials and advanced research to enhance patient care. It is the first hospital in the UAE accredited by both the Accreditation Council for Graduate Medical Education International (ACGMEI) and the Accreditation Council for Continuing Medical Education (ACCME), offering residency and fellowship programs, undergraduate health professional training, and Continuing Medical Education (CME). M42 is a global, tech-enabled healthcare company based in Abu Dhabi, operating at the forefront of medical advancement. About the American College of Cardiology The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes.
Yahoo
08-02-2025
- Health
- Yahoo
MP concerned over proposed change to cardiac care
Delays to treatment are among the concerns being raised by a proposal to move an out-of-hours cardiac service out of Torbay. The suggested trial comes after two reviews undertaken by a healthcare programme found the joint service across hospitals in the county could be improved. Primary Percutaneous Coronary Intervention (PPCI), an emergency treatment for heart attacks, is currently provided at hospitals in Torbay and Exeter, but the proposal could see the service moved to just the latter. Liberal Democrat MP for Torbay Steve Darling said he was "extremely concerned" at the prospect of losing the procedure from the Torbay area as it could mean "poorer outcomes for patients". He said: "For patients throughout South Devon, clearly Torbay is a lot closer than Exeter, particularly on a busy summer's day. "I'm just concerned that delays in treatment can mean poorer outcomes and I'm looking for a briefing with the hospital to get some reassurances, but also to see if the trial does come out negatively, that they will reverse this decision." In an update to local MPs the Torbay and South Devon NHS Foundation Trust (TSD) said it hoped the temporary change would "demonstrate improved access and equity". "The agreement, which would see both trusts working together with a shared rota, follows input from clinicians and managers from TSD, Royal Devon, NHS Devon and Getting It Right First Time (GIRFT)," it added. Darling said the proposal needed to be tested "a lot more". "I will not compromise on patient care in South Devon," he said. TSD said the full terms and conditions of the test of change were yet to be finalised and the project would not proceed until a rigorous review had taken place. It added: "However, executives at TSD, Royal Devon and NHS Devon, along with GIRFT leaders, have collectively approved the overarching approach, and the plan is to work towards a start date of 17 March for an eight-week period. "Once the pilot has concluded, a full evaluation, including clinical outcomes and experiences of patients, will be externally commissioned to ensure the learning is captured thoroughly and presented back to all cardiology teams and executive colleagues for review." Follow BBC Devon on X, Facebook and Instagram. Send your story ideas to spotlight@ Anger over hospital build programme review Diagnostics centre sees 1,400 people in two months Mixed reactions by MPs on hospitals' revamp plans TSD RD&E GIRFT
BBC News
08-02-2025
- Health
- BBC News
MP concerned over proposed change to South Devon cardiac care
Delays to treatment are among the concerns being raised by a proposal to move an out-of-hours cardiac service out of suggested trial comes after two reviews undertaken by a healthcare programme found the joint service across hospitals in the county could be Percutaneous Coronary Intervention (PPCI), an emergency treatment for heart attacks, is currently provided at hospitals in Torbay and Exeter, but the proposal could see the service moved to just the latter. Liberal Democrat MP for Torbay Steve Darling said he was "extremely concerned" at the prospect of losing the procedure from the Torbay area as it could mean "poorer outcomes for patients". He said: "For patients throughout South Devon, clearly Torbay is a lot closer than Exeter, particularly on a busy summer's day."I'm just concerned that delays in treatment can mean poorer outcomes and I'm looking for a briefing with the hospital to get some reassurances, but also to see if the trial does come out negatively, that they will reverse this decision."In an update to local MPs the Torbay and South Devon NHS Foundation Trust (TSD) said it hoped the temporary change would "demonstrate improved access and equity"."The agreement, which would see both trusts working together with a shared rota, follows input from clinicians and managers from TSD, Royal Devon, NHS Devon and Getting It Right First Time (GIRFT)," it added. Eight-week trial Darling said the proposal needed to be tested "a lot more"."I will not compromise on patient care in South Devon," he said the full terms and conditions of the test of change were yet to be finalised and the project would not proceed until a rigorous review had taken place. It added: "However, executives at TSD, Royal Devon and NHS Devon, along with GIRFT leaders, have collectively approved the overarching approach, and the plan is to work towards a start date of 17 March for an eight-week period."Once the pilot has concluded, a full evaluation, including clinical outcomes and experiences of patients, will be externally commissioned to ensure the learning is captured thoroughly and presented back to all cardiology teams and executive colleagues for review."
